# Personalized DC Vaccine for Lung Cancer

> **NCT02956551** · PHASE1 · UNKNOWN · sponsor: **Sichuan University** · enrollment: 20 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **BIOLOGICAL:** DC vaccine

## Key facts

- **NCT ID:** NCT02956551
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11-30
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-06-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02956551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02956551, "Personalized DC Vaccine for Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02956551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*